Life Scientist > Health & Medical

Moles, eye colour and the genetics of skin cancer

14 November, 2011 by Tim Dean

A new study has identified that a gene variation associated with a greater number of moles and non-blue eye colour is linked to an increased risk of melanoma.


Tackling breast cancer requires national coordination: report

11 November, 2011 by Staff Writers

A new report by the Economist Intelligence Unit says "fragmentation" of research, funding and treatment of breast cancer is hampering Australia's response to the disease.


Feature: New pathways for cancer therapy

08 November, 2011 by Fiona Wylie

Associate Professor Stuart Pitson has been delving into the world of sphingolipid-mediated cell signalling pathways, particularly their enticing possibilities in cancer treatment.


Protein microarray uncovers malaria immunity

03 November, 2011 by Staff Writers

Researchers at the Walter and Eliza Hall institute have revealed some enticing information about how people develop immunity to malaria, opening the door to possible diagnostics and therapies.


Ramaciotti Awards Slideshow

28 October, 2011 by Staff Writers

The Ramaciotti Foundations are collectively one of the largest private contributors to biomedical research in Australia, and having recently celebrated their 40th anniversary, have granted more than $51 million to research projects since 1970. Last week saw the latest slew of awards and grants issued, with more than $2.6 million issued to biomedical researchers around the nation.


Melanoma gene discovery may improve diagnosis and treatment

10 October, 2011 by Tim Dean

Four new genes associated with melanoma susceptibility have been uncovered, revealing insights into skin cancer and raising the prospect of improved diagnosis and treatment.


Feature: Collapsing breast cancer’s niche

05 October, 2011 by Fiona Wylie

Two Sydney researchers coming from entirely different backgrounds have teamed up to find out how the hedgehog pathway is being hijacked by breast cancer calls – with a potential win-win result for patients.


Vegenics files for IND for anti-cancer drug

04 October, 2011 by Staff Writers

Circadian subsidiary, Vegenics, has submitted investigational new drug (IND) application for anti-cancer drug VGX-100.


Fat’s proteomic fingerprint sheds light on Type 2 diabetes

30 September, 2011 by Staff Writers

A proteomic analysis of fat cells has lent insight into the role of insulin, providing potential targets for future Type 2 diabetes treatments.


Insight into how chemotherapy causes low platelets

26 September, 2011 by Staff Writers

New research uncovering how chemotherapy reduces platelet count in cancer patients may lead to new strategies to prevent chemotherapy-induced thrombocytopenia.


Gene ‘switch’ discovered for Type 2 diabetes

23 September, 2011 by Staff Writers

A single gene has been found to control the onset of Type 2 diabetes after eating a high-fat diet, lending hope that a new treatment might be found.


Feature: Dosing the poison

21 September, 2011 by Graeme O'Neill

Associate Professor Martina Stenzel is developing polymer nanoparticles that can help target the effects of chemotherapy drugs on tumours while sparing healthy cells.


Genetic link between schizophrenia and bi-polar discovered

19 September, 2011 by Tim Dean

Two landmark genetic studies have found 11 regions that are associated with both diseases, suggesting some common underlying causes.


Feature: Going rogue

06 September, 2011 by Fiona Wylie

Tony Purcell is using the latest in immunoproteomics technology to detect, monitor and hopefully eliminate rogue T cells that cause autoimmune disease with minimal collateral damage to the good guys.


Trial of xenotransplantation treatment for diabetes kicks off in Argentina

22 August, 2011 by Staff Writers

Living Cell Technologies has begun a trial of its xenotransplantation therapy for the treatment of Type 1 diabetes in Argentina.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd